BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access Email this article to a friend

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

Sandro Pignata*, Sabino De Placido, Rosalbino Biamonte, Giovanni Scambia, Giovanni Di Vagno, Giuseppe Colucci, Antonio Febbraro, Marco Marinaccio, Alessandra Vernaglia Lombardi, Luigi Manzione, Giacomo Cartenì, Mario Nardi, Saverio Danese, Maria R Valerio, Andrea de Matteis, Bruno Massidda, Giampietro Gasparini, Massimo Di Maio, Carmela Pisano and Francesco Perrone

BMC Cancer 2006, 6:5 doi:10.1186/1471-2407-6-5

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.